logo color s and clearside.jpg
Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit
03 oct. 2023 16h35 HE | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
monopar.jpg
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
23 déc. 2019 12h30 HE | Monopar Therapeutics Inc.
CHICAGO, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced the closing of its initial public offering of 1,277,778 shares of common stock, including the underwriters’...
monopar.jpg
Monopar Therapeutics Inc. Announces Full Exercise of Over-Allotment by Underwriters
20 déc. 2019 16h46 HE | Monopar Therapeutics Inc.
CHICAGO, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced that the underwriters of its previously announced initial public offering of common stock have exercised in full...
monopar.jpg
Monopar Therapeutics Inc. Announces Pricing of Initial Public Offering
18 déc. 2019 19h52 HE | Monopar Therapeutics Inc.
CHICAGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced that it has priced an initial public offering of 1,111,112 shares of its common stock at $8.00 per share. The...